| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 17, 2007
From the Department of Neurosurgery, Kyoto University, Graduate School of Medicine, Kyoto (T.A., H.K., T.M., R.I., K.N., N.H.); Department of Advanced Clinical Science and Therapeutics, Tokyo University, Graduate School of Medicine, Tokyo (M.S., K.W.); and Department of Clinical Gene Therapy, Osaka University, Graduate School of Medicine, Osaka (H.N., R.M.), Japan. * To whom correspondence should be addressed. E-mail: kataoka{at}kuhp.kyoto-u.ac.jp.
Background—Subarachnoid hemorrhage caused by the rupture of cerebral aneurysm (CA) remains a life-threatening disease despite recent diagnostic and therapeutic advancements. Recent studies strongly suggest the active participation of macrophage-mediated chronic inflammatory response in the pathogenesis of CA. We examined the role of nuclear factor- Methods and Results—In experimentally induced CAs in rats, NF- Conclusions—Our data indicate that NF-
Accepted on October 9, 2007
NF-
Tomohiro Aoki MD,
B Is a Key Mediator of Cerebral Aneurysm Formation
B (NF-
B) in the pathogenesis of CA formation in this study.
B was activated in cerebral arterial walls in the early stage of aneurysm formation with upregulated expression of downstream genes. NF-
B p50 subunit–deficient mice showed a decreased incidence of CA formation with less macrophage infiltration into the arterial wall. NF-
B decoy oligodeoxynucleotide also prevented CA formation when it was administered at the early stage of aneurysm formation in rats. Macrophage infiltration and expression of downstream genes were dramatically inhibited by NF-
B decoy oligodeoxynucleotide. In human CA walls, NF-
B also was activated, especially in the intima.
B plays a crucial role as a key regulator in the initiation of CA development by inducing some inflammatory genes related to macrophage recruitment and activation. NF-
B may represent a therapeutic target of a novel medical treatment for CA.
Related Article:
Circulation 2007 116: 2773.
This article has been cited by other articles:
![]() |
M. J. DeLeo III, M. J. Gounis, B. Hong, J. C. Ford, A. K. Wakhloo, and A. A. Bogdanov Jr Carotid Artery Brain Aneurysm Model: In Vivo Molecular Enzyme-specific MR Imaging of Active Inflammation in a Pilot Study Radiology, September 1, 2009; 252(3): 696 - 703. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. X. L. Liu, R. Tian, H. Baskind, W. Hsueh, and I. G. De Plaen Platelet-activating factor induces the processing of nuclear factor-{kappa}B p105 into p50, which mediates acute bowel injury in mice Am J Physiol Gastrointest Liver Physiol, July 1, 2009; 297(1): G76 - G81. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Aoki, H. Kataoka, R. Ishibashi, K. Nozaki, R. Morishita, and N. Hashimoto Reduced Collagen Biosynthesis Is the Hallmark of Cerebral Aneurysm: Contribution of Interleukin-1{beta} and Nuclear Factor-{kappa}B Arterioscler Thromb Vasc Biol, July 1, 2009; 29(7): 1080 - 1086. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Aoki, H. Kataoka, R. Ishibashi, K. Nozaki, K. Egashira, and N. Hashimoto Impact of Monocyte Chemoattractant Protein-1 Deficiency on Cerebral Aneurysm Formation Stroke, March 1, 2009; 40(3): 942 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kataoka Response to Letter by Paraskevas Stroke, August 1, 2008; 39(8): e135 - e135. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |